Liquidia Technologies Inc(LQDA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

LQDA Liquidia Technologies Inc

Market Closed 11-13 16:00:00 EST

57.41

-0.71

-1.22%

盘后56.92

-0.49-0.85%

19:54 EST

High59.50	Low57.00	Vol1.93M
Open58.37	D1 Closing58.12	Amplitude4.30%
Mkt Cap5.17B	Tradable Cap4.13B	Total Shares90.11M
T/O112.10M	T/O Rate2.69%	Tradable Shares71.97M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"LQDA","market":"US","secType":"STK","nameCN":"Liquidia Technologies Inc","latestPrice":57.41,"timestamp":1794603600000,"preClose":58.12,"halted":0,"volume":1933075,"hourTrading":{"tag":"盘后","latestPrice":56.9225,"preClose":57.41,"latestTime":"19:54 EST","volume":204449,"amount":11735415.1406,"timestamp":1794617694579,"change":-0.4875,"changeRate":-0.008492,"amplitude":0.024909},"delay":0,"changeRate":-0.012216104611149362,"floatShares":71973928,"shares":90106442,"eps":-1.065589,"marketStatus":"Market Closed","change":-0.71,"latestTime":"11-13 16:00:00 EST","open":58.37,"high":59.5,"low":57,"amount":112104729.55354999,"amplitude":0.043014,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.065589,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1794819600000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1532577600000,"exchange":"NASDAQ","adjPreClose":58.12,"preHourTrading":{"tag":"盘前","latestPrice":58.9997,"preClose":58.12,"latestTime":"09:29 EST","volume":1382,"amount":80243.33410800001,"timestamp":1794580180650,"change":0.8797,"changeRate":0.015136,"amplitude":0.021846},"postHourTrading":{"tag":"盘后","latestPrice":56.9225,"preClose":57.41,"latestTime":"19:54 EST","volume":204449,"amount":11735415.1406,"timestamp":1794617694579,"change":-0.4875,"changeRate":-0.008492,"amplitude":0.024909},"volumeRatio":0.7254602422392757,"impliedVol":0.6907,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/LQDA/wiki","defaultTab":"wiki","newsList":[{"id":"2683680392","title":"How Q3 Results Will Impact Liquidia (LQDA) Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2683680392","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683680392?lang=en_us&edition=fundamental","pubTime":"2026-11-14 14:18","pubTimestamp":1794637096,"startTime":"0","endTime":"0","summary":"MMitch LawlerNovember 14, 2026","market":"sg","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=240/https://images.simplywall.st/asset/industry/6121000-choice1-card/1788949577743","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=240/https://images.simplywall.st/asset/industry/6121000-choice1-card/1788949577743"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-lqda/liquidia/news/how-q3-results-will-impact-liquidia-lqda-investors","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-lqda/liquidia/news/how-q3-results-will-impact-liquidia-lqda-investors","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["VGFPF","LQDA","RGLO","FEBU","BK4007","JOYT","GXDW","BK4211","DECU","VOTE","ISBC","PMDE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683572443","title":"Liquidia assumed with a Buy at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2683572443","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683572443?lang=en_us&edition=fundamental","pubTime":"2026-11-13 19:21","pubTimestamp":1794568873,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Matthew Caufield assumed coverage of Liquidia (LQDA) with a Buy rating and $76 price target The company’s October settlemen...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/liquidia-assumed-with-a-buy-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/liquidia-assumed-with-a-buy-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683154348","title":"Longeveron Q3 Revenue Falls 16% on Absence of Contract Manufacturing","url":"https://stock-news.laohu8.com/highlight/detail?id=2683154348","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683154348?lang=en_us&edition=fundamental","pubTime":"2026-11-13 06:18","pubTimestamp":1794521936,"startTime":"0","endTime":"0","summary":"Longeveron Q3 revenue falls 16% on absence of contract manufacturingOverviewUS biotech firm's Q3 revenue fell 16% yr/yr due to lower contract manufacturing revenueNet loss for Q3 narrowed to $6.1 mln ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261112:nL2N46T1M2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","EQ","LGVN","BK4568","LQDA","BK4139","PRME"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683510433","title":"AnaptysBio Q1 Collaboration Revenue Drops on Lower Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2683510433","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683510433?lang=en_us&edition=fundamental","pubTime":"2026-11-13 05:31","pubTimestamp":1794519094,"startTime":"0","endTime":"0","summary":"CORRECTED-AnaptysBio Q1 collaboration revenue drops on lower milestonesCorrects period in table to Q1 from Q3OverviewUS biotech royalty manager's fiscal Q1 collaboration revenue fell sharply yr/yr due","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261112:nL2N46T1HS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","LU1309081286.SGD","LU0211331839.USD","BK4007","LU2089984988.USD","BK4139","LU0987226296.USD","LU1302929846.USD","LU1400636491.USD","LU0225284248.USD","LU1228905540.USD","RCKT","LU2646069778.SGD","LU0321505868.SGD","LU0225283273.USD","IE0034235071.USD","LU0971552673.USD","LU1645745479.HKD","LU0109981661.USD","LU1983299246.USD","SG9999001176.USD","LU0203345920.USD","LU1400636574.HKD","LU0985481810.HKD","PRME","IE00BQJZX424.USD","IE00B3T34201.USD","ANAB","LU0971552830.HKD","LU1202635105.USD","LU0161305163.EUR","LU0306807586.USD","SG9999001176.SGD","LU1046248800.SGD","LU0203347892.USD","LU0321505439.SGD","GSK.UK","LU2468319806.SGD","LQDA","LU0225771236.USD","LU0545562505.USD","LU0557290698.USD","LU0306806265.USD","LU0289739699.SGD","IE00BWDBJ516.SGD","LU1670756490.USD","LU1015430645.USD","SG9999013999.USD","SGXZ57979304.SGD","LU0575583348.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683102510","title":"Dyadic Q3 Revenue Falls on Lower Grant Activity","url":"https://stock-news.laohu8.com/highlight/detail?id=2683102510","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683102510?lang=en_us&edition=fundamental","pubTime":"2026-11-13 05:30","pubTimestamp":1794519058,"startTime":"0","endTime":"0","summary":"Dyadic Q3 revenue falls on lower grant activityOverviewUS biotechnology firm's Q3 revenue fell 61% yr/yr as grant and R&D revenue declinedCompany's Q3 net loss narrowed from prior year, helped by lowe","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261112:nL2N46T1H5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLRB","BK4139","BK4599","LQDA","LU1878469433.USD","ALT","BK4007","DYAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683510961","title":"Fractyl Health's Q3 Net Loss Narrows as Costs Fall, Shifts Focus to Revita","url":"https://stock-news.laohu8.com/highlight/detail?id=2683510961","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683510961?lang=en_us&edition=fundamental","pubTime":"2026-11-13 05:27","pubTimestamp":1794518829,"startTime":"0","endTime":"0","summary":"Fractyl Health's Q3 net loss narrows as costs fall, shifts focus to RevitaOverviewUS metabolic therapeutics firm's Q3 net loss narrowed from prior year on lower operating expensesCompany announced pla","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261112:nL2N46T1GW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU1878469433.USD","BK4082","ALT","BK4007","BK4599","GUTS","IPSC","BK4505","LQDA","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683951059","title":"Spero Therapeutics Q3 Net Loss Widens on SP001 Licensing Payment","url":"https://stock-news.laohu8.com/highlight/detail?id=2683951059","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683951059?lang=en_us&edition=fundamental","pubTime":"2026-11-13 05:24","pubTimestamp":1794518687,"startTime":"0","endTime":"0","summary":"Spero Therapeutics Q3 net loss widens on SP001 licensing paymentOverviewUS biopharma firm's Q3 revenue fell to zero from $5.4 mln a year earlierNet loss for Q3 widened to $44.3 mln, mainly due to $35 ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261112:nL2N46T1GV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LQDA","SPRO","CLRB","BK4139","LU1878469433.USD","ALT","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683517012","title":"Atrium Therapeutics Q3 Collaboration Revenue Rises on BMS Milestone","url":"https://stock-news.laohu8.com/highlight/detail?id=2683517012","media":"Reuters","labels":["corporation","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683517012?lang=en_us&edition=fundamental","pubTime":"2026-11-13 05:18","pubTimestamp":1794518313,"startTime":"0","endTime":"0","summary":"Atrium Therapeutics Q3 collaboration revenue rises on BMS milestoneOverviewUS biopharma's Q3 collaboration revenue rose, driven by BMS milestone paymentCompany posted Q3 net loss as R&D expenses incre","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261112:nL2N46T1HB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","LU0985481810.HKD","LU0109394709.USD","LU1430594728.SGD","LU1571399168.USD","LU1670711123.USD","LU0868494617.USD","LU2360032135.SGD","LU2596442595.SGD","LU0096364046.USD","LU0267386448.USD","IE00BJT1NW94.SGD","BK4588","LU1868836914.USD","LU2242646821.SGD","LU0320765992.SGD","MEDI","BK4534","IE0009355771.USD","LU1983299246.USD","LU0321505868.SGD","LU1868837136.USD","LU1883839398.USD","LU1323610961.USD","ANNX","ASND","BK4532","BMY","IHE","LU1868836757.USD","BK4007","FTXH","LU1670710588.SGD","BK4559","LQDA","LU0114720955.EUR","LU0225771236.USD","BK4585","LU0321505439.SGD","LU1718418525.SGD","LU0306807586.USD","LU0882574055.USD","LU2125154778.USD","BK4505","LU2125154935.USD","RNA","LU1670710661.SGD","LU1032466523.USD","LU0237698245.USD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683517945","title":"MacroGenics Q3 Swings to Net Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2683517945","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683517945?lang=en_us&edition=fundamental","pubTime":"2026-11-13 05:11","pubTimestamp":1794517871,"startTime":"0","endTime":"0","summary":"MacroGenics Q3 swings to net lossOverviewUS biopharma firm's Q3 revenue fell sharplyCompany reported Q3 net loss, compared to net income a year earlierRecent pipeline progress includes completion of M","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261112:nL2N46T1EM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","IE00B19Z3B42.SGD","IE00B7SZLL34.SGD","SG9999015978.USD","IBB","IBBQ","LU2112291526.USD","LU0965509283.SGD","LU1236620750.USD","LU0823416689.USD","BBH","BMED","MEDI","IE00B19Z3581.USD","LU1839511570.USD","KURA","LU0234570918.USD","BK4568","LU0058720904.USD","BK4550","BK4139","LU1674673691.USD","LU0114720955.EUR","LU1066051498.USD","IE00BSNM7G36.USD","LU1037948897.HKD","TMED","LU1778281490.HKD","LU2065170008.USD","SG9999015986.USD","LU2065171402.SGD","BK4578","LU1674673428.USD","LU2065169927.USD","LU1934455277.USD","LU1934455863.HKD","MGNX","LU1057294990.SGD","TBXU","IE00BKVL7J92.USD","LU1571399168.USD","BIB","LU1585245621.USD","LU0965509010.AUD","BK4007","LU1061106388.HKD","BK4566","LQDA","LU0882574055.USD","GILD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683516996","title":"Liquidia Technologies call volume above normal and directionally bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=2683516996","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683516996?lang=en_us&edition=fundamental","pubTime":"2026-11-13 01:05","pubTimestamp":1794503115,"startTime":"0","endTime":"0","summary":"Bullish option flow detected in Liquidia (LQDA) Technologies with 7,639 calls trading, 1.3x expected, and implied vol increasing over 4 points to 7...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/liquidia-technologies-call-volume-above-normal-and-directionally-bullish-thefly-news-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/liquidia-technologies-call-volume-above-normal-and-directionally-bullish-thefly-news-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136842583","title":"Movement Alert｜Liquidia Technologies Inc Intraday Rise 4.07%, analyst target increases and revenue optimism extend post-earnings momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=1136842583","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136842583?lang=en_us&edition=fundamental","pubTime":"2026-11-12 23:43","pubTimestamp":1794498198,"startTime":"0","endTime":"0","summary":"On November 12, Liquidia Technologies Inc rose 4.07% in Regular Trading, trading at $57.6 per share, with turnover of $25.0313 million.The clearest catalyst behind the move was continued...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"BofA lifts target to $54 as Liquidia extends post-earnings rise","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682595750","title":"CorMedix Q3 Revenue Beats on Higher Sales from Acquired Melinta Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2682595750","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2682595750?lang=en_us&edition=fundamental","pubTime":"2026-11-12 20:41","pubTimestamp":1794487268,"startTime":"0","endTime":"0","summary":"CorMedix Q3 revenue beats on higher sales from acquired Melinta portfolioOverviewU.S. biopharma firm's Q3 revenue rose and beat analyst expectationsQ3 net loss widened and missed analyst expectationsC","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261112:nL2N46T0O1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","HRTX","BK4139","CRMD","LQDA","BK4007","DCTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682593517","title":"EyePoint Pharmaceuticals Q3 Revenue Falls, Net Loss Widens","url":"https://stock-news.laohu8.com/highlight/detail?id=2682593517","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2682593517?lang=en_us&edition=fundamental","pubTime":"2026-11-12 20:12","pubTimestamp":1794485578,"startTime":"0","endTime":"0","summary":"EyePoint Pharmaceuticals Q3 revenue falls, net loss widensOverviewUS biopharma firm's Q3 revenue declined yr/yr as product sales fellQ3 net loss widened on higher R&D expenses for DURAVYU Phase 3 tria","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261112:nL2N46T0LB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU0320765992.SGD","BK4588","LU0889565916.HKD","EYPT","KURA","OCUL","LU2324357040.USD","LU0109394709.USD","BK4585","BK4505","LQDA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682980875","title":"Switzerland's Pharvaris Q3 Loss Widens as Costs Rise","url":"https://stock-news.laohu8.com/highlight/detail?id=2682980875","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2682980875?lang=en_us&edition=fundamental","pubTime":"2026-11-12 20:07","pubTimestamp":1794485232,"startTime":"0","endTime":"0","summary":"Switzerland's Pharvaris Q3 loss widens as costs riseOverviewSwitzerland biopharma firm reported Q3 loss widenedCompany ended Q3 with cash and equivalents of 283 mlnRegulatory review of lead drug deucr","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261112:nL2N46T0L4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IMVT","PHVS","ROIV","BK4588","BK4139","PTH","EDIT","BK4007","LQDA","BK4556"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682567290","title":"Need To Know: Analysts Are Much More Bullish On Liquidia Corporation (NASDAQ:LQDA) Revenues","url":"https://stock-news.laohu8.com/highlight/detail?id=2682567290","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2682567290?lang=en_us&edition=fundamental","pubTime":"2026-11-12 19:21","pubTimestamp":1794482499,"startTime":"0","endTime":"0","summary":"SSasha JovanovicNovember 12, 2026","market":"nz","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=240/https://images.simplywall.st/asset/industry/6121000-choice1-card/1788949577743","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=240/https://images.simplywall.st/asset/industry/6121000-choice1-card/1788949577743"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-lqda/liquidia/news/need-to-know-analysts-are-much-more-bullish-on-liquidia-corp-1","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-lqda/liquidia/news/need-to-know-analysts-are-much-more-bullish-on-liquidia-corp-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":[".IXIC","LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192471686","title":"Movement Alert｜Liquidia Technologies Inc Intraday Rise 5.91%, analyst target increases add to post-earnings momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=1192471686","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192471686?lang=en_us&edition=fundamental","pubTime":"2026-11-11 22:56","pubTimestamp":1794409012,"startTime":"0","endTime":"0","summary":"On November 11, Liquidia Technologies Inc rose 5.91% in Regular Trading, trading at $54.355 per share, with turnover of $22.3646 million.The clearest catalyst was a fresh round of analyst...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"BofA Lifts Target to $54 as Liquidia Surges on YUTREPIA","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100211374","title":"Movement Alert｜Liquidia Technologies Inc rises 5.06% in Pre-Market Trading, analyst target increases add to post-earnings momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=1100211374","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100211374?lang=en_us&edition=fundamental","pubTime":"2026-11-11 22:29","pubTimestamp":1794407356,"startTime":"0","endTime":"0","summary":"On November 11, Liquidia Technologies Inc rose 5.06% in Pre-Market Trading, trading at $54.0 per share, with turnover of $1.3833 million.The latest identified catalyst was a wave of analyst...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"BofA Lifts Target to $54 as Liquidia Surges","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682309620","title":"Liquidia price target raised to $54 from $42 at BofA","url":"https://stock-news.laohu8.com/highlight/detail?id=2682309620","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2682309620?lang=en_us&edition=fundamental","pubTime":"2026-11-11 19:55","pubTimestamp":1794398125,"startTime":"0","endTime":"0","summary":"BofA raised the firm’s price target on Liquidia (LQDA) to $54 from $42 and keeps a Neutral rating on the shares after the company reported Q3 Yutre...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/liquidia-price-target-raised-to-54-from-42-at-bofa-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/liquidia-price-target-raised-to-54-from-42-at-bofa-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682030300","title":"Analysts Offer Insights on Healthcare Companies: Xenon (XENE), Veeva Systems (VEEV) and Liquidia Technologies (LQDA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2682030300","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2682030300?lang=en_us&edition=fundamental","pubTime":"2026-11-11 18:50","pubTimestamp":1794394224,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Xenon (XENE), Veeva Systems (VEEV) and Liquidia Technologies (LQD...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-xenon-xene-veeva-systems-veev-and-liquidia-technologies-lqda-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-xenon-xene-veeva-systems-veev-and-liquidia-technologies-lqda-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2404859741.USD","EKG","BK4139","BK4585","LU0006306889.USD","LU1989764664.SGD","HCSG","BK4588","BK4504","LU0029874061.USD","LU0170899867.USD","LU0289739699.SGD","LQDD","LABU","LU0128526141.USD","BK4581","LQDU","LGHT","XLV","XENE","LU0690374615.EUR","LU1989764748.USD","LU0690374961.EUR","LQD","XBI","BK4007","IBRN","LQDA","LU0266013472.USD","BK4561","BK4528","LU0225283273.USD","BK4534","BK4137","BK4167","LU2404859667.USD","SBIO","GB00B4QBRK32.GBP","LU0106261372.USD","BK4550","BK4613","GB00B4LPDJ14.GBP","LU0058720904.USD","VEEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682303689","title":"BTIG Reaffirms Their Buy Rating on Liquidia Technologies (LQDA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2682303689","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2682303689?lang=en_us&edition=fundamental","pubTime":"2026-11-11 18:38","pubTimestamp":1794393495,"startTime":"0","endTime":"0","summary":"BTIG analyst Julian Harrison reiterated a Buy rating on Liquidia Technologies yesterday and set a price target of $87.00. The company’s shares clos...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/btig-reaffirms-their-buy-rating-on-liquidia-technologies-lqda-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/btig-reaffirms-their-buy-rating-on-liquidia-technologies-lqda-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LQDA"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.liquidia.com","stockEarnings":[{"period":"1week","weight":0.293},{"period":"1month","weight":0.6915},{"period":"3month","weight":-0.2288},{"period":"6month","weight":0.0084},{"period":"1year","weight":1.131},{"period":"ytd","weight":0.6645}],"compareEarnings":[{"period":"1week","weight":0.0259},{"period":"1month","weight":-0.0198},{"period":"3month","weight":-0.0283},{"period":"6month","weight":0.0206},{"period":"1year","weight":0.1225},{"period":"ytd","weight":0.1062}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company also offers Remodulin, a treprostinil administered through continuous intravenous and subcutaneous infusion. The company also a license agreement with Pharmosa Biopharm Inc to develop and commercialize L606, an inhaled sustained-release formulation of Treprostinil for the treatment of PAH and PH-ILD. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.081499},{"month":2,"riseRate":0.75,"avgChangeRate":0.042796},{"month":3,"riseRate":0.5,"avgChangeRate":-0.012167},{"month":4,"riseRate":0.375,"avgChangeRate":-0.058158},{"month":5,"riseRate":0.875,"avgChangeRate":0.19539},{"month":6,"riseRate":0.25,"avgChangeRate":-0.029487},{"month":7,"riseRate":0.375,"avgChangeRate":0.004032},{"month":8,"riseRate":0.444444,"avgChangeRate":0.021851},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.017529},{"month":10,"riseRate":0.666667,"avgChangeRate":0.077362},{"month":11,"riseRate":0.777778,"avgChangeRate":0.097034},{"month":12,"riseRate":0.75,"avgChangeRate":0.150821}],"exchange":"NASDAQ","name":"Liquidia Technologies Inc","nameEN":"Liquidia Technologies Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Liquidia Technologies Inc(LQDA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Liquidia Technologies Inc(LQDA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Liquidia Technologies Inc,LQDA,Liquidia Technologies Inc股票,Liquidia Technologies Inc股票老虎,Liquidia Technologies Inc股票老虎国际,Liquidia Technologies Inc行情,Liquidia Technologies Inc股票行情,Liquidia Technologies Inc股价,Liquidia Technologies Inc股市,Liquidia Technologies Inc股票价格,Liquidia Technologies Inc股票交易,Liquidia Technologies Inc股票购买,Liquidia Technologies Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Liquidia Technologies Inc(LQDA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Liquidia Technologies Inc(LQDA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}